ARCHIVES

FDA Didn’t Tell Advisors About Data Linking Obesity Drug With Precancerous Lesions.

This article is from The Cancer Letter archive.

Vol. 32 No. 21 | June 2, 2006

Download PDF Visit The Full Archive

Related Articles

Hey Doc, Wanna Score Some Leucovorin? Drugs Available at 80 Times the Price

October 14, 2011

VEGF Levels Can Predict Tumor’s Resistance to Avastin

July 29, 2011

Symposium Planned On Hyperthermia

April 23, 1976

Cancer Center Directors to Develop Blueprint for Progress That’s “Honest,” M.D. Anderson’s John Mendelsohn Says.

November 22, 2006

NCI Programs: Advisors Approve Recompetition of Phase II Contracts

July 9, 1999

Growth Of The Cost of Drugs Slows to 5.4 Percent per Year; 21 Therapies Launched in 2 Years

May 9, 2014